Clin2
NCT05084196Possibly a fitRecruiting

Melatonin to help prevent kidney damage from vancomycin

Acute Kidney InjuryAdverse Drug Event

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This Phase 3 study tests whether melatonin can help protect the kidneys in people who are starting or continuing vancomycin, an antibiotic that can sometimes affect kidney function. If you qualify, you would take melatonin as an added prevention step while you’re on vancomycin.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Be between 18 and 75 years old
  • Be currently being treated with vancomycin and expected to stay on it for at least 3 days
  • Have kidney filtration (creatinine clearance) estimated at 30 mL/min or higher
  • Not have severe liver problems (liver enzymes more than 3 times the usual upper limit)
  • Be able to take pills by mouth and not require a breathing machine (mechanical ventilation)
  • Not be pregnant or breastfeeding, and not have a melatonin allergy or a condition that makes you unable to take melatonin

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06954129Recruiting· Phase 4
Comparing two antibiotic combos for infection and kidney safety

This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.

Philadelphia, Pennsylvania
NCT07818265Not yet recruiting
Comparing kidney safety of two antibiotic combinations

This study compares two common antibiotic combinations to see which one is safer for your kidneys. It uses a special blood test (cystatin-C) alongside standard tests to get a clearer picture of kidney function.

Riyadh
NCT06886464Recruiting· Phase 2
Preventing kidney injury from strong medications with cilastatin

This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.

Calgary, Alberta
NCT07556107Recruiting· Phase 4
Safety study of two antibiotics for serious hospital infections

This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.

Worcester, Massachusetts
NCT07739290Not yet recruiting
Vitamin B3 to prevent kidney injury after heart surgery

This study tests whether giving a vitamin B3 supplement (nicotinamide) before, during, and after heart surgery can help protect the kidneys from injury. If you are having heart surgery and have a higher risk of kidney damage, this treatment might reduce that risk.

NCT07084129Recruiting· Phase 1
Vancomycin and kidney injury study for children with sepsis

This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.

Philadelphia, Pennsylvania

Hear when a new Acute Kidney Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.